Medicine, Hematology Oncology Division

Grants

Grants per year 1995 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2028

• 117 Active
• 1280 Finished

Grants per year

Search results

• The Robert H. Lurie Comprehensive Cancer Center: Program Leaders

  Longnecker, R. M., Bulun, S. E., Catalona, W. J., Cella, D., Eklund, E. A., Lee, C., Longnecker, R. M., O'Halloran, T. V., Tallman, M. S., Catalona, W. J., Eklund, E. A., Khan, S. A., Lee, C., Longnecker, R. M., O'Halloran, T. V., Spring, B. & Tallman, M. S.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • Malignant Neoplasm 100%
  • Cancer Center 100%
  • cancer 100%
  • universities 37%
  • Hospital 28%

• The Robert H. Lurie Comprehensive Cancer Center - Administrative Core

  Benson III, A. B., Bulun, S. E., Catalona, W. J., Chatterton Jr, R. T., Chisholm, R. L., Chmiel, J. S., Goolsby, C. L., Gordon, L. I., Greenland, P., Jovanovic, B., Kibbe, M. R., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Platanias, L. C., Rademaker, A. W., Scholtens, D. M., Tallman, M. S., Tourtellotte, W., Woodruff, T. K., Yang, X. J., Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W., Tallman, M. S. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • Malignant Neoplasm 100%
  • Cancer Center 100%
  • cancer 100%
  • universities 37%
  • Hospital 28%

• The Robert H. Lurie Comprehensive Cancer Center: CPSRMS

  Benson III, A. B., Benson III, A. B. & Benson III, A. B.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • Malignant Neoplasm 100%
  • Cancer Center 100%
  • cancer 100%
  • universities 37%
  • Hospital 28%

• The Robert H. Lurie Comprehensive Cancer Center - CURE Supplement

  Leikin, R. G., Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Leikin, R. G., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W., Tallman, M. S. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

• The Robert H. Lurie Comprehensive Cancer Center: Faculty Development Award for Dr. Eklund

  Eklund, E. A.

  National Cancer Institute

  8/1/01 → 7/31/02

  Project: Research project

  • Malignant Neoplasm 100%
  • Cancer Center 100%
  • cancer 100%
  • awards 100%
  • Development 100%

• The Robert H. Lurie Comprehensive Cancer Center - Administrative Core

  Benson III, A. B., Bulun, S. E., Catalona, W. J., Chatterton Jr, R. T., Chisholm, R. L., Chmiel, J. S., Goolsby, C. L., Gordon, L. I., Greenland, P., Jovanovic, B., Kibbe, M. R., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Platanias, L. C., Rademaker, A. W., Scholtens, D. M., Tallman, M. S., Tourtellotte, W., Woodruff, T. K., Yang, X. J., Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W., Tallman, M. S. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

• The Robert H. Lurie Comprehensive Cancer Center: Protocol Specific

  Kuzel, T. M., Kuzel, T. M. & Kuzel, T. M.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

• Recombinant Interleuckin-12 for Cutaneous T-Cell Lymphoma

  Kuzel, T. M.

  University of Pennsylvania, National Cancer Institute

  8/10/01 → 7/31/06

  Project: Research project

• Prot# GL 303: Randomized Study of Fludarabine and Cyclophosphamide With or Without Genasense? (Bcl-2 Antisense Oligonucleotide) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

  Tallman, M. S.

  Inveresk Research, Inc., Genta Incorporated

  9/24/01 → 8/22/07

  Project: Research project

• Prot# C-100-12: A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® versus Observation in Patients with High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma (NDDO Oncology Prot# ND 030012)

  Kuzel, T. M. & Kozlowski, J. M.

  Agenus Inc.

  10/7/01 → 1/1/11

  Project: Research project

• Prot# 524E-CVD-0042-029: Thromboprophylaxis with Low Molecular Weight Heparin (Fragmin) vs Warfarin in Patients Undergoing Primary Total Knee Replacement

  Green, D.

  Pharmacia & Upjohn, Inc.

  12/17/01 → 1/1/11

  Project: Research project

• Molecularly Targeted Therapy for CML

  Tallman, M. S.

  Oregon Health and Science University, Leukemia & Lymphoma Society

  1/1/02 → 6/30/05

  Project: Research project

• Quality of Life Among Inner-City White and African-American Prostate Cancer Patients

  Chmiel, J. S., Golub, R. M., Kuzel, T. M. & Nadler, R. B.

  American Cancer Society

  1/1/02 → 12/31/06

  Project: Research project

• Quality of Life Among Inner-City White and African-American Prostate Cancer Patients

  Chmiel, J. S., Golub, R. M., Kuzel, T. M. & Nadler, R. B.

  American Cancer Society

  1/1/02 → 12/31/06

  Project: Research project

• HoxA10 Function During Myeloid Differentiation

  Eklund, E. A.

  National Cancer Institute

  2/6/02 → 1/31/08

  Project: Research project

• HoxA10 Function During Myeloid Differentiation

  Eklund, E. A.

  National Cancer Institute

  2/6/02 → 1/31/08

  Project: Research project

  • Myeloid 100%
  • genes 100%
  • phosphorylation 100%
  • CYBB 85%
  • proteins 80%

• Prot# CpG-C010: A Phase II, Open Label, Multi-Center, Single Arm, Two-Stage Study for the Evaluation of CpG 7909 in Patients with Stage IV Renal Cell Carcinoma

  Kuzel, T. M.

  Coley Pharmaceutical Group, Inc.

  3/19/02 → 3/19/06

  Project: Research project

• Prot# CpG-C010: A Phase II, Open Label, Multi-Center, Single Arm, Two-Stage Study for the Evaluation of CpG 7909 in Patients with Stage IV Renal Cell Carcinoma

  Kuzel, T. M.

  Coley Pharmaceutical Group, Inc.

  3/19/02 → 3/19/06

  Project: Research project

• Prot# CEPO906A2212: An Open-Label, Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 (Epothilone B) as Therapy in Patients with Metastatic Carcinoid Tumors

  Benson III, A. B.

  Novartis Pharmaceuticals Corporation

  4/1/02 → 3/3/10

  Project: Research project

• Prot# IDEC 114-20: A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

  Gordon, L. I.

  IDEC Pharmaceuticals Corporation

  4/23/02 → 1/1/11

  Project: Research project

• Prot# 0903X-100847: Prospective Observational Study of Mylotarg® (Gemtuzumab Ozogamicin) in Usual Care

  Tallman, M. S.

  MILLENNIX, Inc. and etrials, Inc., Wyeth-Ayerst

  5/1/02 → 10/31/03

  Project: Research project

• Prot# 0903X-100847: Prospective Observational Study of Mylotarg® (Gemtuzumab Ozogamicin) in Usual Care

  Tallman, M. S.

  MILLENNIX, Inc. and etrials, Inc., Wyeth-Ayerst

  5/1/02 → 10/31/03

  Project: Research project

• West Hemophilia Treatment Center Network, Region V--MCHB Cooperative Grant

  Zakarija, A.

  Great Lakes Hemophilia Foundation, Maternal and Child Health Bureau

  6/1/02 → 5/31/12

  Project: Research project

• End of Life Nursing Education through Graduate Programs

  Paice, J.

  City of Hope National Medical Center and Beckman Research Institute, National Cancer Institute

  7/1/02 → 6/30/07

  Project: Research project

• Prot# EFC3558: Mltctr, Rndmzd, Dbl-Bld, Prl'l Grp Trial to Demonstrate Efficacy of Fondaparinux Sodium in Assoct'n w/ Intermittent Pneumatic Compression vs Intermittent Pneumatic Compression used Alone for Prevention of Venous Thromboembolic Events in Hig

  Green, D.

  Sanofi-Synthelabo Inc.

  8/21/02 → 1/1/11

  Project: Research project